Neurocrine Biosciences (NBIX) DMA 200 (1997 - 2026)

Neurocrine Biosciences (NBIX) DMA 200 (1997 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	DMA 200
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn	28.15
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn	123.73
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn	488.41
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn	4.25
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn	140.38
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn	22.38
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn	31.57
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn	69.00
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn	33.89
10	Liquidia	5.63 Bn	5.40 Bn	121.79 Mn	35.24

Download Data